These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 34090145)

  • 1. Transcutaneous Vagus Nerve Stimulation (t-VNS) and epilepsy: A systematic review of the literature.
    Lampros M; Vlachos N; Zigouris A; Voulgaris S; Alexiou GA
    Seizure; 2021 Oct; 91():40-48. PubMed ID: 34090145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial.
    Yang H; Shi W; Fan J; Wang X; Song Y; Lian Y; Shan W; Wang Q
    Neurotherapeutics; 2023 Apr; 20(3):870-880. PubMed ID: 36995682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial.
    He W; Wang XY; Zhou L; Li ZM; Jing XH; Lv ZL; Zhao YF; Shi H; Hu L; Su YS; Zhu B
    Trials; 2015 Aug; 16():371. PubMed ID: 26292720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy.
    Aihua L; Lu S; Liping L; Xiuru W; Hua L; Yuping W
    Epilepsy Behav; 2014 Oct; 39():105-10. PubMed ID: 25240121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagus nerve stimulation for conservative therapy-refractive epilepsy and depression.
    Möbius H; Welkoborsky HJ
    Laryngorhinootologie; 2022 May; 101(S 01):S114-S143. PubMed ID: 35605616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation.
    Rong P; Liu A; Zhang J; Wang Y; Yang A; Li L; Ben H; Li L; Liu R; He W; Liu H; Huang F; Li X; Wu P; Zhu B
    Chin Med J (Engl); 2014; 127(2):300-4. PubMed ID: 24438620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.
    Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S
    J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review.
    Toffa DH; Touma L; El Meskine T; Bouthillier A; Nguyen DK
    Seizure; 2020 Dec; 83():104-123. PubMed ID: 33120323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of quality of life (QOL) in patients with epilepsy and comorbid psychogenic nonepileptic seizures (PNES) after vagus nerve stimulation (VNS).
    Vivas AC; Reitano CJ; Waseem H; Benbadis SR; Vale FL
    Epilepsy Behav; 2017 Aug; 73():208-213. PubMed ID: 28651170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Treatment with Transcutaneous Vagus Nerve Stimulation in 17 Patients with Refractory Epilepsy Evaluated by Electroencephalogram, Seizure Frequency, and Quality of Life.
    Liu A; Rong P; Gong L; Song L; Wang X; Li L; Wang Y
    Med Sci Monit; 2018 Nov; 24():8439-8448. PubMed ID: 30467307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
    Chambers A; Bowen JM
    Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review.
    Redgrave J; Day D; Leung H; Laud PJ; Ali A; Lindert R; Majid A
    Brain Stimul; 2018; 11(6):1225-1238. PubMed ID: 30217648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy.
    Wasade VS; Schultz L; Mohanarangan K; Gaddam A; Schwalb JM; Spanaki-Varelas M
    Epilepsy Behav; 2015 Dec; 53():31-6. PubMed ID: 26515157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial.
    He W; Jing X; Wang X; Rong P; Li L; Shi H; Shang H; Wang Y; Zhang J; Zhu B
    Epilepsy Behav; 2013 Sep; 28(3):343-6. PubMed ID: 23820114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous vagal nerve stimulatio (t-VNS): An adjunctive treatment option for refractory epilepsy.
    Barbella G; Cocco I; Freri E; Marotta G; Visani E; Franceschetti S; Casazza M
    Seizure; 2018 Aug; 60():115-119. PubMed ID: 29940349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy.
    von Wrede R; Surges R
    Auton Neurosci; 2021 Nov; 235():102840. PubMed ID: 34246121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagus nerve stimulation for the treatment of epilepsy: things to note on the protocols, the effects and the mechanisms of action.
    Abdullahi A; Etoom M; Badaru UM; Elibol N; Abuelsamen AA; Alawneh A; Zakari UU; Saeys W; Truijen S
    Int J Neurosci; 2024 Jun; 134(6):560-569. PubMed ID: 36120993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial.
    Ryvlin P; Gilliam FG; Nguyen DK; Colicchio G; Iudice A; Tinuper P; Zamponi N; Aguglia U; Wagner L; Minotti L; Stefan H; Boon P; Sadler M; Benna P; Raman P; Perucca E
    Epilepsia; 2014 Jun; 55(6):893-900. PubMed ID: 24754318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.